Thanks for the link @IndexInvestor. Agree, I cant help but think there must be other hormone related applications for a drug which mitigates high cortisol in the brain. Again, Depression and Alzheimer's are the key markets but shows there could be alot of off label opportunities further down the line.
Anyway bring on Alzheimers results with compound annual growth rate (CAGR) of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8 major markets and depression an even bigger market.
More and more eyes will be on ACW on a world stage as they get closer to results.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.001(2.63%) |
Mkt cap ! $60.36M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $36.90K | 1.908M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 3131005 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 861915 | 3 |
View Market Depth
| Last trade - 12.29pm 23/06/2025 (20 minute delay) ? |
| ACW (ASX) Chart |